SWITCHING INFLIXIMAB TO SUBCUTANEOUS FROM INTRAVENOUS THERAPY (SWIMSUIT) - A PROSPECTIVE, REAL-WORLD PHASE IV INTERVENTIONAL STUDY

被引:0
|
作者
Rahmany, Sohail [1 ]
Young, David [1 ]
Moyses, Helen [2 ]
Gonclaves, Joao [3 ]
Latter, Sue [4 ]
Cummings, Fraser [1 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Southampton Gen Hosp, NIHR Biomed Res Unit, Southampton, Hants, England
[3] Univ Lisbon, IMed Res Inst Med, Dept Pharm, Lisbon, Portugal
[4] Univ Southampton, Sch Hlth Sci, Southampton, Hants, England
关键词
D O I
10.1136/gutjnl-2023-BSG.152
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P80
引用
收藏
页码:A92 / A93
页数:2
相关论文
共 50 条
  • [41] CLINICAL EFFICACY AND DURABILITY OF SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH MODERATE-TO-SEVERE INFLAMMATORY BOWEL DISEASE: A REAL-WORLD MULTICENTER PROSPECTIVE COHORT STUDY IN KOREA
    Kim, Kyuwon
    Hong, Sung Noh
    Kang, Sang-Bum
    Lee, Kang-Moon
    Koo, Ja Seol
    Jung, Yunho
    Lee, Beom Jae
    Yoon, Hyuk
    Kim, Hyung Wook
    Lim, Yun Jeong
    Lee, Hyun Seok
    Lee, Yoo Jin
    Lee, Jun
    Lee, Chang Kyun
    Moon, Jung Min
    Shin, Seung Yong
    Seo, Jeongkuk
    Choi, Chang Hwan
    GASTROENTEROLOGY, 2024, 166 (05) : S1137 - S1137
  • [42] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [43] Switching from intravenous to oral antibiotic therapy in the treatment of infective endocarditis: a case series and literature review of real-world data
    Lundgren, Lorenzo Brando
    Albertini, Lorenzo
    De Bona, Anna
    Tincati, Camilla
    Augello, Matteo
    Marchetti, Giulia
    JAC-ANTIMICROBIAL RESISTANCE, 2025, 7 (02):
  • [44] Prospective, Non-interventional Study on the Real-World Use of Certoparin in Daily Practice-The PROMEMBER Study
    Spannagl, Michael
    Melzer, Nima
    Bramlage, Peter
    Englert, Cornelia
    Eisele, Ralf
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (01) : 86 - 91
  • [45] Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study
    Fulcher, Gregory R.
    Cohen, Neale D.
    Davies, Katherine
    d'Emden, Michael
    Glastras, Sarah J.
    Mah, Peak M.
    McCallum, Roland W.
    Moses, Robert
    Thong, Ken Y.
    Roberts, Anthony
    INTERNAL MEDICINE JOURNAL, 2024, 54 (10) : 1626 - 1633
  • [46] Efficacy and Safety of Brivaracetam in Persons With Epilepsy in a Real-World Setting: A Prospective, Non-Interventional Study
    Siddiqui, Fowzia
    Soomro, Bashir A.
    Badshah, Mazhar
    Rehman, Ehsan U.
    Numan, Ahsan
    Ikram, Amer
    Khan, Muhammad Wazir Ali
    Ali, Sajjad
    Hashim, Husnain
    Salam, Jawwad-us
    Akram, Asad
    Hashmat, Muhammad Irfan
    Iqbal, Shahid
    Javed, Muhammad Zeeshan
    Iqbal, S. Zafar
    Maqsood, Atif
    Khan, Assadullah
    Maheshwary, Neeta
    Khan, Muhammad Athar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [47] Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
    Wiken, Thea H.
    Hoivik, Marte L.
    Anisdahl, Karoline
    Buer, Lydia
    Warren, David J.
    Bolstad, Nils
    Hagen, Milada
    Moum, Bjorn A.
    Medhus, Asle W.
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [48] phase IV study to evaluate the safety of fruquintinib in Chinese real-world clinical practice
    Li, Jin
    Wang, Zhi-Qiang
    Zhong, Haijun
    He, Yifu
    Zhang, Chen
    Niu, Zuoxing
    Yang, Shujun
    Zhang, Tao
    Zhu, Liangjun
    Shu, Yongqian
    Peng, Jianjun
    Song, Yan
    Li, Jian
    Yuan, Ying
    Zhang, Haibo
    Yu, Gengsheng
    Hua, Yun-Qi
    Xiao, Jianjun
    Shi, Michael
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry
    Faraawi, R.
    Chow, A.
    Khraishi, M.
    Haaland, D.
    Nantel, F.
    Osborne, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 371 - 371
  • [50] One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study
    Hong, Sung Noh
    Song, Joo Hye
    Kim, Sung Jin
    Park, Yoon Ha
    Choi, Chang Wan
    Kim, Ji Eun
    Kim, Eun Ran
    Chang, Dong Kyung
    Kim, Young-Ho
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (04) : 517 - 528